Company Overview

Update
Headquarters:
Valencia, CA
IPO:
Went Public on Jul 28, 2004
Stock:
MNKD
Categories:
Health Care, Biotechnology
Description:
MannKind Corporation focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.

Detailed Description

Update

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA(R) , is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind.

Current Team (6)

Update

Funding Rounds (2) - $200M

Update

Board Members and Advisors (12)

Update

Offices/Locations (1)

Update
  • Headquarters

    28903 North Avenue Paine

    Valencia, CA 91355

    USA

Images (1)

Update
  • 62ffc2f2281ece2814e30ab0d5b48300